Funding considerations for the disclosure of genetic incidental findings in biobank research

Clinical Genetics

Volumn 84, Issue 5, 2013, Pages 397-406

  Black, L ^a   Avard, D ^a   Zawati, Mh ^a   Knoppers, Bm ^a   Hebert J ^b,c   Sauvageau, G ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Biobank; Disclosure; Ethics; Incidental findings; Research

Indexed keywords

BIOBANK; CLINICAL ASSESSMENT TOOL; CLINICAL PROTOCOL; COMMUNITY; DATA BASE; ETHICIST; FUNDING; GENETIC ANALYSIS; GENETICS; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; INCIDENTAL FINDING; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; MEDICAL RESEARCH; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCIENTIST; TISSUES;

BIOBANK; DISCLOSURE; ETHICS; INCIDENTAL FINDINGS; RESEARCH;

BIOLOGICAL SPECIMEN BANKS; GENOMICS; GUIDELINES AS TOPIC; HUMANS; INCIDENTAL FINDINGS; TRUTH DISCLOSURE;

EID: 84885835292     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12190     Document Type: Review

References (66)

1. Burton PR, Hansell AL, Fortier I et al. Size matters: just how big is BIG? Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol 2009: 38: 263-273.
2. Wolf SM, Lawrenz FP, Nelson CA et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 2008: 36: 219-248.
3. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. Ottawa, 2010.
4. Bredenoord AL, Kroes HY, Cuppen E, Parker M, Van Delden JJM. Disclosure of individual genetic data to research participants: the debate reconsidered. Trends Genet 2011: 27: 41-47.
5. Bredenoord AL, Onland-Moret NC, Van Delden JJM. Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy. Hum Mutat 2011: 32: 861-867.
6. Shalowitz DI, Miller FG. Disclosing individual results of clinical research: implications of respect for participants. JAMA 2005: 294: 737-740.
7. Miller FA, Christensen R, Giacomini M, Robert JS. Duty to disclose what? Querying the putative obligation to return research results to participants. J Med Ethics 2008: 34: 210-213.
8. Ossorio PN. Letting the gene out of the bottle: a comment on returning individual research results to participants. Am J Bioeth 2006: 6: 24-25.
9. Parker L. Rethinking respect for persons enrolled in research. ASBH Exch 2006: 9: 6-7.
10. Clayton EW, McGuire AL. The legal risks of returning results of genomics research. Genet Med 2012: 14: 473-477.
11. Bledsoe MJ, Clayton EW, McGuire AL, Grizzle WE, O'Rourke PP, Zeps N. Return of research results from genomic biobanks: cost matters. Genet Med 2013: 15: 103-105.
12. World Health Organization (WHO). Genetic Databases: Assessing the Benefits and the Impact on Human & Patients Rights. Geneva, 2003.
13. United Nations Educational Scientific and Cultural Organization (UNESCO). International Declaration on Human Genetic Data. Paris, 2003.
14. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, 2002.
15. Council for International Organizations of Medical Sciences (CIOMS). Ethical Guidelines for Epidemiological Studies. Geneva, 2008.
16. International Epidemiological Association. Good Epidemiological Practice (GEP)-IEA Guidelines for Proper Conduct in Epidemiological Research. Raleigh, 2007.
17. Renegar G, Webster CJ, Stuerzebecher S et al. Returning genetic research results to individuals: points-to-consider. Bioethics 2006: 20: 24-36.
18. Organisation for Economic Co-operation and Development (OECD). OECD Guidelines on Human Biobanks and Genetic Research Databases. Paris, 2009.
19. Council of Europe. Additional Protocol to the Convention on Human Rights and Biomedicine, Concerning Biomedical Research. Strasbourg, 2005.
20. Council of Europe, Committee of Ministers. Recommendation R(97)5 on the Protection of Medical Data. Strasbourg, 1997.
21. Government of Estonia. Human Genes Research Act. (RT I 2000, 104, 685), 2000.
22. Japan Ministry of Education Culture Sports Science and Technology, Ministry of Health Labour and Welfare, Ministry of Economy Trade and Industry. Ethical Guidelines for Analytical Research on the Human Genome/Genes. Tokyo, 2001.
23. Government of Spain. Law 14/2007, of 3 July, on Biomedical Research. 2007.
24. National Health and Medical Research Council, Australian Research Council, Australian Vice-Chancellors' Committee. National Statement on Ethical Conduct in Human Research-Updated 2009. Canberra, 2007.
25. Government of Western Australia Department of Health. Guidelines for Human Biobanks, Genetic Research Databases and Associated Data. Perth, 2010.
26. Office of Biorepositories and Biospecimen Research, National Cancer Institute, National Institutes of Health. Workshop Summary. Workshop on Release of Research Results to Participants in Biospecimen Studies. Bethesda, 2010.
27. National Human Genome Research Institute. Federal Policy Recommendations Including HIPAA. Bethesda, 2012.
28. Fabsitz RR, McGuire A, Sharp RR et al. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute Working Group. Circ Cardiovasc Genet 2010: 3: 574-580.
29. National Bioethics Advisory Committee Research Involving Human Biological Materials: Ethical Issues and Policy Guidance. vol I, Bethesda, 1999
30. Medical Research Council (UK). Human Tissue and Biological Samples for use in Research-Operational and Ethical Guidelines. London, 1999.
31. Nuffield Council on Bioethics. Pharmacogenetics: Ethical Issues. London, 2003.
32. Canadian College of Medical Geneticists, Canadian Association of Genetic Counsellors. Joint Statement on the Process of Informed Consent for Genetic Research. Ottawa, 2008.
33. Presidential Commission for the Study of Bioethical Issues. Privacy and Progress in Whole Genome Sequencing. Washington, DC, 2012.
34. Bledsoe MJ, Clayton EW, McGuire AL, Grizzle WE, O'Rourke PP, Zeps N. Return of research results from genomic biobanks: a call for data. Genet Med 2013: 15: 159-160.
35. Terry SF. The tension between policy and practice in returning research results and incidental findings in genomic biobank research. Minn J Law Sci Technol 2012: 13: 691-736.
36. Knoppers BM, Joly Y, Simard J, Durocher F. The emergence of an ethical duty to disclose genetic research results: international perspectives. Eur J Hum Genet 2006: 14: 1170-1178.
37. Klitzman R. Questions, complexities, and limitations in disclosing individual genetic results. Am J Bioeth 2006: 6: 34-36.
38. Meacham MC, Starks H, Burke W, Edwards K. Researcher perspectives on disclosure of incidental findings in genetic research. J Empir Res Hum Res Ethics 2010: 5: 31-41.
39. Cassa CA, Savage SK, Taylor PL, Green RC, McGuire AL, Mandl KD. Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. Genome Res 2012: 22: 421-428.
40. Lévesque E, Joly Y, Simard J. Return of research results: general principles and international perspectives. J Law Med Ethics 2011: 39: 583-592.
41. Johnson AD, Bhimavarapu A, Benjamin EJ et al. CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Genet Med 2010: 12: 355-363.
42. Van Ness B. Genomic research and incidental findings. J Law Med Ethics 2008: 36: 292-297.
43. Miller FG, Mello MM, Joffe S. Incidental findings in human subjects research: what do investigators owe research participants? J Law Med Ethics 2008: 36: 271-279.
44. Lo B. Responding to incidental findings on research imaging studies: now what? Arch Intern Med 2010: 170: 1522-1524.
45. Richardson HS. Incidental findings and ancillary-care obligations. J Law Med Ethics 2008: 36: 256-270.
46. Zawati MH, Van Ness B, Knoppers BM. Incidental findings in genomic research: a review of international norms. GenEdit 2011: 9: 1-8.
47. Cho MK. Understanding incidental findings in the context of genetics and genomics. J Law Med Ethics 2008: 36: 280-285.
48. Wolf SM, Crock BN, Van Ness B et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012: 14: 361-384.
49. Fernandez CV, Skedgel C, Weijer C. Considerations and costs of disclosing study findings to research participants. Can Med Assoc J 2004: 170: 1417-1419.
50. Wolf SM, Paradise J, Caga-anan C. The law of incidental findings in human subjects research: establishing researchers' duties. J Law Med Ethics 2008: 36: 361-383.
51. Green RC, Berg JS, Grody WW et al. ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. Bethesda: American College of Medical Genetics and Genomics, 2013.
52. Knoppers BM, Deschênes M, Zawati MH, Tassé AM. Population studies: return of research results and incidental findings Policy Statement. Eur J Hum Genet 2013: 21: 245-247.
53. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Agreement on the Administration of Agency Grants and Awards by Research Institutions. Ottawa, 2013.
54. Gliwa C, Berkman BE. Do researchers have an obligation to actively look for genetic incidental findings? Am J Bioethics 2013: 13: 32-42.
55. Dressler LG. Disclosure of research results from cancer genomic studies: state of the science. Clin Cancer Res 2009: 15: 4270-4276.
56. Pyeritz RE. The coming explosion in genetic testing-is there a duty to recontact? N Engl J Med 2011: 365: 1367-1369.
57. Silversides A. The wide gap between genetic research and clinical needs. Can Med Assoc J 2007: 176: 315-316.
58. Thorogood A, Knoppers BM, Dondorp WJ, de Wert GMWR. Whole genome sequencing and the physician. Clin Genet 2012: 81: 511-513.
59. Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA 2006: 296: 212-215.
60. Yassin R, Weil C, Lockhart N. Sharing individual research results with biospecimen contributors: point. Cancer Epidemiol Biomarkers Prev 2012: 21: 256-259.
61. Clayton EW. Sharing individual research results with biospecimen contributors: counterpoint. Cancer Epidemiol Biomarkers Prev 2012: 21: 260-261.
62. Black L, McClellan KA, Avard D, Knoppers BM. Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J Community Genet 2013: 4: 203-214.
63. Troy DE. The unfunded mandates reform act of 1995. Admin Law Rev 1997: 49: 139-147.
64. Coriell Personalized Medicine Collaborative. Informed Cohort Oversight Board (ICOB). Camden, 2012.
65. Fernandez C. Public expectations for return of results-time to stop being paternalistic? Am J Bioethics 2008: 8: 46-48.
66. Bookman EB, Langehorne AA, Eckfeldt JH et al. Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet A 2006: 140A: 1033-1040.